D. E. Shaw & Co., Inc. Intuitive Surgical Inc Call Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$416.14 - $494.01 $50 Million - $59.3 Million	-120,100 Reduced 73.82%	42,600 $20.9 Million
Q2 2024 Aug 14, 2024	BUY	$366.34 - $445.11 $37.8 Million - $45.9 Million	103,100 Added 172.99%	162,700 $72.4 Million
Q1 2024 May 15, 2024	BUY	$322.13 - $400.59 $18.8 Million - $23.4 Million	58,300 Added 4484.62%	59,600 $23.8 Million
Q4 2023 Feb 14, 2024	SELL	$258.49 - $338.39 $5.35 Million - $7 Million	-20,700 Reduced 94.09%	1,300 $438,000
Q3 2023 Nov 14, 2023	SELL	$284.35 - $354.93 $2.7 Million - $3.37 Million	-9,500 Reduced 30.16%	22,000 $6.43 Million
Q2 2023 Aug 14, 2023	SELL	$253.53 - $341.94 $5.02 Million - $6.77 Million	-19,800 Reduced 38.6%	31,500 $10.8 Million
Q1 2023 May 15, 2023	SELL	$224.75 - $271.36 $8.63 Million - $10.4 Million	-38,400 Reduced 42.81%	51,300 $13.1 Million
Q4 2022 Feb 14, 2023	BUY	$183.06 - $281.74 $2.07 Million - $3.18 Million	11,300 Added 14.41%	89,700 $23.8 Million
Q2 2022 Aug 15, 2022	SELL	$190.71 - $305.54 $3.81 Million - $6.11 Million	-20,000 Reduced 20.33%	78,400 $15.7 Million
Q1 2022 May 16, 2022	SELL	$262.77 - $360.0 $8.67 Million - $11.9 Million	-33,000 Reduced 25.11%	98,400 $29.7 Million
Q4 2021 Feb 14, 2022	BUY	$319.93 - $365.42 $22.5 Million - $25.7 Million	70,400 Added 115.41%	131,400 $47.2 Million
Q3 2021 Nov 15, 2021	SELL	$309.15 - $360.85 $9.12 Million - $10.6 Million	-29,500 Reduced 32.6%	61,000 $60.6 Million
Q2 2021 Aug 16, 2021	BUY	$249.2 - $306.91 $12.5 Million - $15.3 Million	50,000 Added 123.46%	90,500 $83.2 Million
Q1 2021 May 17, 2021	BUY	$228.3 - $272.92 $3.13 Million - $3.74 Million	13,700 Added 51.12%	40,500 $29.9 Million
Q4 2020 Feb 16, 2021	SELL	$222.36 - $272.7 $111,180 - $136,350	-500 Reduced 1.83%	26,800 $21.9 Million
Q3 2020 Nov 16, 2020	SELL	$190.43 - $255.04 $6.57 Million - $8.8 Million	-34,500 Reduced 55.83%	27,300 $19.4 Million
Q2 2020 Aug 14, 2020	BUY	$152.75 - $197.59 $4.7 Million - $6.09 Million	30,800 Added 99.35%	61,800 $35.2 Million
Q1 2020 May 15, 2020	SELL	$122.58 - $206.1 $4.9 Million - $8.24 Million	-40,000 Reduced 56.34%	31,000 $15.4 Million
Q3 2019 Nov 14, 2019	SELL	$161.53 - $181.67 $3.07 Million - $3.45 Million	-19,000 Reduced 21.11%	71,000 $38.3 Million
Q2 2019 Aug 14, 2019	SELL	$152.76 - $195.3 $2.29 Million - $2.93 Million	-15,000 Reduced 14.29%	90,000 $47.2 Million
Q1 2019 May 15, 2019	SELL	$150.08 - $192.66 $11.6 Million - $14.9 Million	-77,300 Reduced 42.4%	105,000 $59.9 Million
Q4 2018 Feb 14, 2019	SELL	$144.96 - $191.58 $2.17 Million - $2.87 Million	-15,000 Reduced 7.6%	182,300 $87.3 Million
Q3 2018 Nov 14, 2018	BUY	$161.86 - $191.4 $3.29 Million - $3.89 Million	20,300 Added 11.47%	197,300 $113 Million
Q2 2018 Aug 14, 2018	BUY	$132.18 - $165.17 $3.07 Million - $3.83 Million	23,200 Added 15.08%	177,000 $84.7 Million
Q1 2018 May 15, 2018	SELL	$125.08 - $149.94 $14.3 Million - $17.2 Million	-114,700 Reduced 42.72%	153,800 $63.5 Million
Q4 2017 Feb 14, 2018	BUY	$117.83 - $134.57 $22.3 Million - $25.4 Million	189,000 Added 237.74%	268,500 $98 Million
Q3 2017 Nov 14, 2017	BUY	$103.26 - $116.26 $8.21 Million - $9.24 Million	79,500	79,500 $83.1 Million

Others Institutions Holding ISRG

# of Institutions

2,140

Shares Held

285M

Call Options Held

2.27M

Put Options Held

2.54M

Vanguard Group Inc Valley Forge, PA

31.9M
Shares

$16.8 Billion
0.29% of portfolio
Black Rock Inc. New York, NY

30.1M
Shares

$15.9 Billion
0.31% of portfolio
State Street Corp Boston, MA

15.1M
Shares

$7.93 Billion
0.31% of portfolio
Price T Rowe Associates Inc Baltimore, MD

14.6M
Shares

$7.69 Billion
0.83% of portfolio
Jpmorgan Chase & CO New York, NY

10M
Shares

$5.27 Billion
0.4% of portfolio

View Full List

About INTUITIVE SURGICAL INC

Ticker ISRG
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 353,384,992
Market Cap $186B
Description
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endo...

More about ISRG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account